Since 2006, the FDA has cautioned physicians to advise their depression patients of the risk of Paxil (paroxetine) for women who are pregnant or may become pregnant. The FDA’s caution was well-founded: medical studies have shown that mothers who took selective serotonin reuptake inhibitors (SSRIs) after the twentieth week of pregnancy were six times more likely to give birth to infants suffering from persistent pulmonary hypertension (PPHN) and other serious birth defects.
If your child suffers or suffered from PPHN, then you know that treatments can be costly, painful for the newborn, and emotionally taxing on the entire family. Common treatments for PPHN include inserting a tube into the baby’s trachea in order to increase oxygen levels in the blood and administering chemical compounds like sodium bicarbonate and nitric oxide. If these methods don’t work, some doctors have had success with an intensive procedure extracorporeal membrane oxygenation (ECMO), a major and complicated surgery that can produce its own side effects.
Fears Nachawati knows well just how much pain and suffering as well as financial costs these kind of medical procedures can cause. That’s why we’ve decided to jump in the trenches with SSRI victims and join in the fight to bring them justice. Fortunately through legal mechanisms like our dangerous drug class action lawsuit, qualified Paxil patients may achieve the justice they deserve. To find out if you qualify and how you might stand to benefit, contact our professionals immediately. For a free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com.